Literature DB >> 12402292

Fibronectin receptor reduction in skin and fibroblasts of patients with Ullrich's disease.

Jing Hu1, Itsuro Higuchi, Tadafumi Shiraishi, Masahito Suehara, Takahito Niiyama, Takashi Horikiri, Yuichi Uchida, Akiko Saito, Mitsuhiro Osame.   

Abstract

Ullrich's disease is a congenital muscular dystrophy characterized clinically by generalized muscle weakness, multiple contractures of the proximal joints, and hyperextensibility of the distal joints. Recent studies have demonstrated that collagen VI is deficient in the muscles of patients with Ullrich's disease, and some cases result from recessive mutations of the collagen VIalpha2 gene (COL6A2). Fibronectin is one of the main components of the extracellular matrix (ECM) and associates with a variety of other matrix molecules including collagen. The behavior of fibronectin on cells is mediated by fibronectin receptors, members of the integrin family. We studied the expression of fibronectin receptors and fibronectin in patients with Ullrich's disease, and found a marked reduction of fibronectin receptors in the ECM of skin and cultured fibroblasts of these patients. These results suggest that collagen VI deficiency may lead to the reduction of fibronectin receptors and that an abnormality of cell adhesion may be involved in the pathogenesis of Ullrich's disease. Copyright 2002 Wiley Periodicals, Inc. Muscle Nerve 26: 696-701, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402292     DOI: 10.1002/mus.10250

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

Review 1.  Collagen VI related muscle disorders.

Authors:  A K Lampe; K M D Bushby
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

2.  Accumulation of type VI collagen in the primary osteon of the rat femur during postnatal development.

Authors:  Yukihiro Kohara; Satoshi Soeta; Yayoi Izu; Hajime Amasaki
Journal:  J Anat       Date:  2015-05-05       Impact factor: 2.610

3.  Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies.

Authors:  Matteo Bovolenta; Marcella Neri; Elena Martoni; Anna Urciuolo; Patrizia Sabatelli; Marina Fabris; Paolo Grumati; Eugenio Mercuri; Enrico Bertini; Luciano Merlini; Paolo Bonaldo; Alessandra Ferlini; Francesca Gualandi
Journal:  BMC Med Genet       Date:  2010-03-19       Impact factor: 2.103

4.  Bethlem myopathy in a Portuguese patient - case report.

Authors:  Ana Inês Martins; Cristin Maarque; Jorge Pinto-Basto; Luis Negrão
Journal:  Acta Myol       Date:  2017-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.